The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.
about
Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10Understanding the interplay between host immunity and Epstein-Barr virus in NPC patientsTRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapyThe MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiationTyrosine 129 of the murine gammaherpesvirus M2 protein is critical for M2 function in vivoEpstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivoTheodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumorsMurine gammaherpesvirus M2 protein induction of IRF4 via the NFAT pathway leads to IL-10 expression in B cellsExpression of EBV encoded viral RNA 1, 2 and anti-inflammatory cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic implication in PakistanLPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanismsEBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switchingNuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options.Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas.Inhibition of p38 MAPK activity in B-NHL Raji cells by treatment with engineered CD20-specific T cells.Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle.Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation.Murine gammaherpesvirus M2 antigen modulates splenic B cell activation and terminal differentiation in vivo.Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function.An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591.Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.Interplay Between Microenvironmental Abnormalities and Infectious Agents in Tumorigenesis.Induction of interleukin-10 expression through Fcalpha receptor in human monocytes and monocyte-derived dendritic cells: role of p38 MAPKinase.
P2860
Q24306761-30B56A07-3A07-4B48-B6E8-A9B0CA5B66B1Q26823898-1873C590-8D98-40D3-B36A-76F55A5CE73AQ28361340-4F02AFF3-52EF-4B3B-8463-EC7AF6D95241Q30837949-7A45A062-5D27-46DF-B84E-C5A2DB181F8CQ33305203-3DCF4C64-F383-47A8-9E93-33DF74968B5CQ33326982-5FDD2D75-298D-440A-AA53-BED9430AA031Q34047454-3A8E3319-2D51-4B26-88BA-F12312116198Q34123985-2AE7E214-1E13-476E-9BEF-7921CC078531Q34374436-D8C6701C-F9C8-4D83-82BD-896CF0C2C54FQ34586289-EA036544-81DD-44BC-9CD2-5A5F659776DBQ34767204-1202DE3E-EA57-4366-A12C-56635E5E824CQ35082220-7EA52DA2-21EC-4A45-974B-101FAF1899BAQ35168623-526BE981-962A-4790-BAA8-EB6EDAB72985Q36148425-FF6CB101-FD7B-44F8-9285-721F81E9E66AQ36222552-63592BE7-B93C-4A3F-9525-6E8493D08F74Q36961875-071432F4-0A99-400C-A719-3FF23F281D5EQ37247067-487A1557-18F3-4260-ABAA-A1DC6836BE84Q38720593-D09FBBC7-C73F-433D-BE0A-D49F08A972A0Q38942281-E67564DA-1100-4819-AAC5-5647F4F8C0C0Q39305171-282A89AD-DA6F-4877-9C08-F17C4B01E87CQ39379903-6102C9ED-6EE7-45F0-AB94-6949CBD0E3F1Q39578093-1188C46A-DCBD-4E4E-9467-0A4DE0ADDEFDQ39736828-3A1DB1BC-B6C1-4A60-8351-5A9F46D90E45Q40096496-870FA3C6-9F07-4301-A973-75F0C1F7B826Q40098067-1F544E1D-7A5A-4B14-BC79-D1DDA2030B8EQ40156856-79D56685-ECDE-42E4-9E43-8C0C09557992Q40689379-6E1CCC66-BEC8-4A3F-8162-8B5904A8603CQ42122014-37B22C4C-7DD5-45DE-AD0E-4EA1ED8E4BE0Q47606249-1A1B351F-2390-4C1C-A15A-B76CE375BA7AQ54445810-FAFBB1E4-1DE0-4D38-A99E-E852525A38AA
P2860
The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The Epstein-Barr virus latent ...... volving the p38/SAPK2 pathway.
@ast
The Epstein-Barr virus latent ...... volving the p38/SAPK2 pathway.
@en
type
label
The Epstein-Barr virus latent ...... volving the p38/SAPK2 pathway.
@ast
The Epstein-Barr virus latent ...... volving the p38/SAPK2 pathway.
@en
prefLabel
The Epstein-Barr virus latent ...... volving the p38/SAPK2 pathway.
@ast
The Epstein-Barr virus latent ...... volving the p38/SAPK2 pathway.
@en
P2093
P921
P356
P1433
P1476
The Epstein-Barr virus latent ...... volving the p38/SAPK2 pathway.
@en
P2093
P304
P356
10.1006/VIRO.2000.0768
P407
P577
2001-02-01T00:00:00Z